Ignite Creation Date:
2025-12-24 @ 5:01 PM
Ignite Modification Date:
2026-01-21 @ 5:18 AM
Study NCT ID:
NCT03634150
Status:
WITHDRAWN
Last Update Posted:
2021-10-26
First Post:
2018-06-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer
Sponsor:
Immune System Key Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-06
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-21
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-20
First Submit QC Date:
None
Study First Post Date:
2018-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-18
Last Update Post Date:
2021-10-26
Last Update Post Date Type:
ACTUAL